Do you have the same question? Follow this Question
May 13, 2026 - 08:32 AM
We’ve provided several answers to questions related to Striverdi Respimat (Olodaterol) , see some other helpful Q&A related to this product.
Question: Is this product compatible with acute episodes of COPD?
Answer: No, this medication should not be used to treat acute worsening of COPD symptoms. It is intended for long-term maintenance therapy, not for immediate relief during sudden breathing problems.
Question: What is the ChEBI number for Olodaterol?
Answer: The ChEBI number is 82700. ChEBI (Chemical Entities of Biological Interest) numbers are used in biological databases to uniquely identify chemical substances.
Question: What is the DrugBank number for Olodaterol?
Answer: The DrugBank number is DB09080. DrugBank is a database for drug and drug target information, providing valuable data for researchers and clinicians.
Question: What is the legal status of this medication?
Answer: This medication is classified as Rx-Only, meaning it is available by prescription only. Prescription-only status ensures the medication is used under medical supervision for safety.
Question: What is the protein binding percentage for Olodaterol?
Answer: Olodaterol has a protein binding of approximately 60%. Protein binding affects how much of the drug is available to act on the body, which can influence both effectiveness and duration of action.
Question: How many puffs are in each inhaler?
Answer: Each inhaler provides 60 puffs, which is enough for 30 doses. Having a set number of doses helps users and caregivers monitor medication use and plan for timely refills.
Question: What form does this medication come in?
Answer: This medication is available as an inhalation spray to be used by mouth. Using an inhalation spray delivers the medicine directly to the lungs, which can lead to faster and more effective relief of breathing symptoms.
View all Striverdi Respimat (Olodaterol) Questions & Answers
